-
1.
公开(公告)号:US5721255A
公开(公告)日:1998-02-24
申请号:US387765
申请日:1995-02-15
申请人: Harry R. Howard , Masami Nakane , Masaya Ikunaka , Kunio Satake , Terry J. Rosen , John A. Lowe, III , Brian T. O'Neill , Fumitaka Ito
发明人: Harry R. Howard , Masami Nakane , Masaya Ikunaka , Kunio Satake , Terry J. Rosen , John A. Lowe, III , Brian T. O'Neill , Fumitaka Ito
IPC分类号: C07D333/36 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/403 , A61K31/41 , A61K31/425 , A61K31/435 , A61K31/4427 , A61K31/445 , A61K31/451 , A61P9/08 , A61P11/16 , A61P25/02 , A61P25/18 , A61P25/20 , A61P25/24 , A61P25/26 , A61P29/00 , A61P37/00 , A61P37/08 , C07D207/14 , C07D209/52 , C07D211/56 , C07D401/12 , C07D417/12 , C07D453/02 , C07D487/08 , A61K31/47
CPC分类号: C07D401/12 , C07D211/56 , C07D417/12 , C07D453/02 , C07D487/08
摘要: The present invention relates to novel substituted benzylamino nitrogen containing non-aromatic heterocycles and, specifically, to compounds of the formula ##STR1## wherein W, R.sup.1, R.sup.2, R.sup.3 and A are as defined in the specification, and to intermediates used in the synthesis of such compounds. The novel compounds of formula I are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders.
摘要翻译: PCT No.PCT / US93 / 04063。 371日期1995年2月15日 102(e)日期1995年2月15日PCT提交1993年5月5日PCT公布。 公开号WO94 / 04496 1994年3月3日本发明涉及新的取代的苄基氨基氮的非芳族杂环,具体地说,涉及下式化合物其中W,R1,R2,R3和A如说明书中所定义, 用于合成这些化合物的中间体。 式I的新型化合物可用于治疗炎性和中枢神经系统疾病以及其它疾病。
-
公开(公告)号:US5852038A
公开(公告)日:1998-12-22
申请号:US950043
申请日:1996-11-18
IPC分类号: C07D453/02 , A61K31/445
CPC分类号: C07D453/02
摘要: ##STR1## Compounds of formula (1), wherein W, Ar
1 , Ar
2 and Ar
3 are defined as below; and the pharmaceutically acceptable salts of such compounds. These compounds are substance P antagonists and useful in the treatment of gastrointestinal disorders, inflammatory disorders, central nervous system disorders and pain.摘要翻译: (I)式(1)的化合物,其中W,Ar 1,Ar 2和Ar 3如下定义; 和这些化合物的药学上可接受的盐。 这些化合物是物质P拮抗剂,可用于治疗胃肠道疾病,炎性疾病,中枢神经系统疾病和疼痛。
-
公开(公告)号:US5837711A
公开(公告)日:1998-11-17
申请号:US428240
申请日:1995-04-28
IPC分类号: C07D453/02 , A61K31/44
CPC分类号: C07D453/02
摘要: Certain novel substituted quinuclidine compounds having the ability to antagonize substance P and having the following formula: ##STR1## wherein Ar.sup.1 and Ar.sup.2 are each, independently, thienyl, phenyl, fluorophenyl, chlorophenyl or bromophenyl; X is --CONR.sup.3 R.sup.4, --CO.sub.2 R.sup.3, --CH.sub.2 OR.sup.3, --CH.sub.2 NR.sup.3 R.sup.4 or --CONR.sup.3 OR.sup.4 ; R.sup.1, R.sup.3 and R.sup.4 are each, independently, hydrogen or alkyl having 1 to 4 carbon atoms; R.sup.2 is alkyl having 1 to 4 carbon atoms; Y is alkylsulfonyl having 1 to 4 carbon atoms, N-alkyl-N-alkanoylamino (which may be substituted by halogen in the alkanoyl moiety) having 1 to 4 carbon atoms in the alkyl and the alkanoyl moieties, N-alkyl-N-alkylsulfonylamino (which may be substituted by halogen in the alkylsulfonyl moiety) having 1 to 4 carbon atoms in the alkyl and the alkyl sulfonyl moieties, alkenyl having 2 to 4 carbon atoms, alkynyl having 2 to 4 carbon atoms, halosubstituted alkyl having 1 to 4 carbon atoms, alkylamino having 1 to 4 carbon atoms, alkanoylamino (which may be substituted by halogen) having 1 to 4 carbon atoms or alkylsulfonylamino (which may be substituted by halogen) having 1 to 4 carbon atoms. These compounds are useful in the treatment gastrointestinal or central nervous system disorders and the alleviation of inflammatory diseases, asthma, pain and migraine in mammals and as the active ingredient in pharmaceutical compositions for treating such conditions.
摘要翻译: PCT No.PCT / US93 / 09169 Sec。 371日期:1995年4月28日 102(e)日期1995年4月28日PCT 1993年9月30日PCT公布。 出版物WO94 / 10170 日期:1994年5月11日具有拮抗物质P并具有下式的新颖取代的奎宁环化合物:其中Ar 1和Ar 2各自独立地为噻吩基,苯基,氟苯基,氯苯基或溴苯基; X是-CONR 3 R 4,-CO 2 R 3,-CH 2 OR 3,-CH 2 NR 3 R 4或-CONR 3 OR 4; R 1,R 3和R 4各自独立地为氢或具有1至4个碳原子的烷基; R2是具有1至4个碳原子的烷基; Y是具有1至4个碳原子的烷基磺酰基,在烷基和烷酰基部分中具有1至4个碳原子的N-烷基-N-烷酰基氨基(其可被烷酰基部分中被卤素取代)为N-烷基-N-烷基磺酰基氨基 (其可以被烷基磺酰基部分中的卤素取代)在烷基和烷基磺酰基部分中具有1至4个碳原子,具有2至4个碳原子的烯基,具有2至4个碳原子的炔基,具有1至4个碳原子的卤代烷基 原子,具有1至4个碳原子的烷基氨基,具有1至4个碳原子的烷酰基氨基(其可以被卤素取代)或具有1至4个碳原子的烷基磺酰基氨基(可被卤素取代)。 这些化合物可用于治疗哺乳动物的胃肠道或中枢神经系统疾病和减轻炎性疾病,哮喘,疼痛和偏头痛,并用作用于治疗这些病症的药物组合物中的活性成分。
-
公开(公告)号:US5716965A
公开(公告)日:1998-02-10
申请号:US175353
申请日:1993-12-20
IPC分类号: C07D453/02 , A61K31/445
CPC分类号: C07D453/02
摘要: Compounds of the formula ##STR1## wherein W, Ar.sup.1, Ar.sup.2 and Ar.sup.3 are defined as below; and the pharmaceutically acceptable salts of such compounds. These compounds are substance P antagonists and useful in the treatment of gastrointestinal disorders, inflammatory disorders, central nervous system disorders and pain.
摘要翻译: PCT No.PCT / US92 / 04002 Sec。 371日期:1993年12月20日 102(e)1993年12月20日日期PCT提交1992年5月19日PCT公布。 出版物WO92 / 20676 日期:1992年11月26日其中W,Ar 1,Ar 2和Ar 3如下定义的式(Ⅰ)化合物: 和这些化合物的药学上可接受的盐。 这些化合物是物质P拮抗剂,可用于治疗胃肠道疾病,炎性疾病,中枢神经系统疾病和疼痛。
-
公开(公告)号:US5086062A
公开(公告)日:1992-02-04
申请号:US529971
申请日:1990-05-29
申请人: Kazuo Ando , Nobuko Asai , Fumitaka Ito , Takashi Mano , Masami Nakane , Kunio Satake , Kaoru Shimada
发明人: Kazuo Ando , Nobuko Asai , Fumitaka Ito , Takashi Mano , Masami Nakane , Kunio Satake , Kaoru Shimada
IPC分类号: C12N9/99 , A61K31/42 , A61K31/423 , A61K31/424 , A61K31/435 , A61K31/445 , A61P29/00 , A61P37/08 , A61P43/00 , C07D263/58 , C07D407/02 , C07D409/12 , C07D413/12 , C07D493/08
CPC分类号: C07D263/58 , C07D413/12 , C07D493/08 , Y02P20/55
摘要: This invention relates to certain benzoxazolinones which inhibit lipoxygenase and/or cyclooxygenase enzymes. Such compounds are useful in inhibiting such enzymes, per se, and are useful in treating allergic and inflammatory conditions in a mammal. This invention also relates to methods of inhibiting lipoxygenase and/or cyclooxygenase in a mammal with such benzoxazolinones; methods of treating an allergic condition in a mammal with such compounds; methods of treating an inflammatory condition in a mammal with such compounds; and pharmaceutical compositions comprising the benzoxazolinones hereof.
-
公开(公告)号:US6083943A
公开(公告)日:2000-07-04
申请号:US280403
申请日:1999-03-19
申请人: Masaya Ikunaka , Yuji Shishido , Masami Nakane
发明人: Masaya Ikunaka , Yuji Shishido , Masami Nakane
IPC分类号: A61K31/40 , A61K31/445 , C07D207/14 , C07D211/56
CPC分类号: A61K31/40 , A61K31/445 , C07D207/14 , C07D211/56
摘要: A compound of the chemical formula (I) and its pharmaceutically acceptable salt: ##STR1## wherein Y is C.sub.2 -C.sub.4 alkylene; Z is a valence bond or C.sub.1 -C.sub.6 alkylene; R.sup.1 is substituted or unsubstituted aryl (e.g., phenyl and naphthyl) or heteroaryl (e.g., thienyl and furyl); R.sup.2 is hydrogen or C.sub.1 -C.sub.6 alkyl; R.sup.3 is hydrogen, hydroxy or the like; R.sup.4 is substituted or unsubstituted benzyl or the like. Typical examples are (2S*,3S*,4R*,5R*)-4-Carboxy-3-[N-(5-Isopropyl-2-methoxy-benzyl)amino]-5-methyl-2-phenylpyrrolidine and (2S*,3S*,5S*)-5-Carboxy-3-[N-(2-methoxy-5-trifluoromethoxybenzyl)amino]-2-phenylpiperidine. The novel substituted azaheterocyclecarboxylic acids in this invention have excellent substance P antagonistic activity and are thus useful for the treatment of gastrointestinal disorders, central nervous system disorders, allergy, inflammatory diseases, asthma, pain, emesis or migraine in mammals, especially humans.
摘要翻译: 化学式(I)的化合物及其药学上可接受的盐:其中Y是C 2 -C 4亚烷基; Z是价键或C1-C6亚烷基; R 1是取代或未取代的芳基(例如苯基和萘基)或杂芳基(例如噻吩基和呋喃基); R2是氢或C1-C6烷基; R3是氢,羟基等; R4是取代或未取代的苄基等。 典型实例是(2S *,3S *,4R *,5R *)-4-羧基-3- [N-(5-异丙基-2-甲氧基 - 苄基)氨基] -5-甲基-2-苯基吡咯烷和(2S *,3S *,5S *)-5-羧基-3- [N-(2-甲氧基-5-三氟甲氧基苄基)氨基] -2-苯基哌啶。 本发明中的新型取代的氮杂环羧酸具有优异的物质P拮抗活性,因此可用于治疗哺乳动物,特别是人类的胃肠疾病,中枢神经系统疾病,变态反应,炎性疾病,哮喘,疼痛,呕吐或偏头痛。
-
公开(公告)号:US5569662A
公开(公告)日:1996-10-29
申请号:US313289
申请日:1994-10-03
申请人: Kunio Satake , Hiroaki Wakabayashi , Masami Nakane
发明人: Kunio Satake , Hiroaki Wakabayashi , Masami Nakane
IPC分类号: C07D453/02 , A61K31/445
CPC分类号: C07D453/02
摘要: Compounds useful in the treatment of inflammatory disorders, central nervous system disorders and other disorders of formula (I) and the pharmaceutically-acceptable salts thereof, wherein X.sup.1 is alkoxy or halosubstituted alkoxy; X.sup.2 is hydrogen, halogen, alkyl, alkenyl, alkynyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, halosubstitued alkyl, halosubstituted alkoxy, alkylamino, dialkylamino, alkylsulfonylamino (which may be substituted), N-alkyl-N-alkylsulfonylamino (which may be substituted), alkanoylamino (which may be substituted) or N-alkyl-N-alkanoylamino (which may be substituted); Ar.sup.1 and Ar.sup.2 are each, independently, thienyl, phenyl, fluorophenyl, chlorophenyl or bromophenyl; A is Y--(CH.sub.2).sub.m --CH(R.sup.2)--(CH.sub.2).sub.n --NR.sup.1 --; R.sup.1 is hydrogen, alkyl, benzyl or --(CH.sub.2).sub.p --Y; R.sup.2 is hydrogen, alkyl (which may be substituted), benzyl, 4-hydroxybenzyl, 3-indolylmethyl or --(CH.sub.2).sub.p --Y; Y is --CN, --CH.sub.2 Z or --COZ; Z is hydroxy, amino, alkoxy, alkylamino or dialkylamino; m, n and p are each, independently, 0, 1, 2 or 3; and R.sup.1 and R.sup.2 may be connected to form a ring.
摘要翻译: PCT No.PCT / US93 / 01810 Sec。 371日期:1994年10月3日 102(e)日期1994年10月3日PCT 1993年3月5日PCT公布。 WO93 / 19064 PCT公开号 日期1993年9月30日可用于治疗炎症性疾病,中枢神经系统疾病和式(I)的其它病症及其药学上可接受的盐的化合物,其中X1是烷氧基或卤代取代的烷氧基; X 2是氢,卤素,烷基,烯基,炔基,烷氧基,烷硫基,烷基亚磺酰基,烷基磺酰基,卤素取代的烷基,卤代烷氧基,烷基氨基,二烷基氨基,烷基磺酰基氨基(其可被取代的),N-烷基-N-烷基磺酰基氨基 ),烷酰基氨基(其可以被取代)或N-烷基-N-烷酰基氨基(其可以被取代); Ar1和Ar2各自独立地为噻吩基,苯基,氟苯基,氯苯基或溴苯基; A是Y-(CH 2)m -CH(R 2) - (CH 2)n -NR 1; R1是氢,烷基,苄基或 - (CH2)p-Y; R 2是氢,烷基(其可以被取代),苄基,4-羟基苄基,3-吲哚基甲基或 - (CH 2)p-Y; Y是-CN,-CH2Z或-COZ; Z是羟基,氨基,烷氧基,烷基氨基或二烷基氨基; m,n和p各自独立地为0,1,2或3; 并且R1和R2可以连接形成环。
-
公开(公告)号:US5504095A
公开(公告)日:1996-04-02
申请号:US359709
申请日:1994-12-20
申请人: Masami Nakane , Kunio Satake , Kazuo Ando , Hiroaki Wakabayashi
发明人: Masami Nakane , Kunio Satake , Kazuo Ando , Hiroaki Wakabayashi
IPC分类号: C07D275/06 , C07D279/02 , C07D285/00 , C07D285/14 , C07D285/15 , C07D285/16 , C07D291/08 , C07D417/12 , C07D419/12 , A61K31/41
CPC分类号: C07D275/06 , C07D279/02 , C07D285/14 , C07D285/15 , C07D285/16 , C07D291/08 , C07D417/12 , C07D419/12
摘要: Aminobenzosultam derivatives, which are inhibitors of lipoxygenase, having the formula ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein Ar is cycloalkyl having five to seven carbon atoms, tetrahydropyranyl, pyridyl, oxazolyl, phenyl or substituted phenyl wherein said substituent is methyl, methoxy, fluoro, chloro or trifluoromethyl; n is an integer of 1 to 3; X is hydrogen, methyl, methoxy, fluoro, chloro or trifluoromethyl; Z is --NH--, --O--, or --CH.sub.2 --; and R.sup.1 is hydrogen or alkyl having one to three carbon atoms.
摘要翻译: 作为脂氧合酶抑制剂的氨基苯并磺酰胺衍生物,其具有式
及其药学上可接受的酸加成盐,其中Ar是具有5-7个碳原子的环烷基,四氢吡喃基,吡啶基,恶唑基,苯基或取代的苯基,其中所述取代基是甲基 ,甲氧基,氟,氯或三氟甲基; n为1〜3的整数。 X是氢,甲基,甲氧基,氟,氯或三氟甲基; Z是-NH-,-O-或-CH 2 - ; 并且R 1是氢或具有1-3个碳原子的烷基。 -
公开(公告)号:US5886009A
公开(公告)日:1999-03-23
申请号:US500958
申请日:1995-06-19
申请人: Fumitaka Ito , Hiroshi Kondo , Masami Nakane , Kaoru Shimada
发明人: Fumitaka Ito , Hiroshi Kondo , Masami Nakane , Kaoru Shimada
IPC分类号: A61K31/435 , A61P1/00 , A61P9/08 , A61P9/12 , A61P11/00 , A61P17/00 , A61P25/00 , A61P25/02 , A61P25/04 , A61P25/18 , A61P25/20 , A61P25/24 , A61P25/26 , A61P25/28 , A61P25/30 , A61P29/00 , A61P37/00 , A61P37/08 , A61P43/00 , C07D453/02
CPC分类号: A61K31/435 , C07D453/02
摘要: This invention relates to the quinuclidine derivative (2S, 3S)-N-(5-n-propyl-2-methoxyphenyl)methyl-2-diphenylmethyl-1-azabicyclo�2.2.2!octan-3-amine and its pharmaceutically acceptable salts. These compounds are substance P antagonists and are useful in the treatment of gastrointestinal disorders, inflammatory disorders, central nervous system disorders and pain.
摘要翻译: PCT No.PCT / US93 / 06624 Sec。 371日期:1995年6月19日 102(e)1995年6月19日PCT PCT 1993年7月19日PCT公布。 公开号WO94 / 11368 日期:5月26日,本发明涉及奎宁环衍生物(2S,3S)-N-(5-正丙基-2-甲氧基苯基)甲基-2-二苯基甲基-1-氮杂双环[2.2.2]辛-3-胺和 其药学上可接受的盐。 这些化合物是物质P拮抗剂,可用于治疗胃肠道疾病,炎性疾病,中枢神经系统疾病和疼痛。
-
公开(公告)号:US5807867A
公开(公告)日:1998-09-15
申请号:US211120
申请日:1994-05-23
申请人: Fumitaka Ito , Hiroshi Kondo , Masami Nakane , Kaoru Shimada , John Adams Lowe, III , Terry Jay Rosen
发明人: Fumitaka Ito , Hiroshi Kondo , Masami Nakane , Kaoru Shimada , John Adams Lowe, III , Terry Jay Rosen
IPC分类号: C07D453/02 , A01N43/90 , A61K20060101 , A61K31/395 , A61K31/435 , A61K31/439 , A61K31/44 , A61K31/445 , A61P1/00 , A61P1/16 , A61P11/00 , A61P25/00 , A61P25/04 , A61P25/20 , A61P25/24 , A61P29/00 , A61P43/00 , C07D20060101 , C07D453/00 , C07D453/04 , C07D471/10
CPC分类号: C07D453/02
摘要: Compounds of the formula ##STR1## wherein R.sup.1 is methoxy and R.sup.2 is selected from the group consisting of methyl, ethyl, isopropyl, sec-butyl and tert-butyl; and the pharmaceutically acceptable salts of such compounds. These compounds are substance P antagonists and useful in the treatment of gastrointestinal disorders, inflammatory disorders, central nervous system disorders and pain.
摘要翻译: PCT No.PCT / US92 / 03317。 371日期1994年5月23日 102(e)日期1994年5月23日PCT提交1992年4月28日PCT公布。 出版物WO92 / 21677 日期:1992年12月10日化学式为其中R 1为甲氧基且R 2选自甲基,乙基,异丙基,仲丁基和叔丁基的式 和这些化合物的药学上可接受的盐。 这些化合物是物质P拮抗剂,可用于治疗胃肠道疾病,炎性疾病,中枢神经系统疾病和疼痛。
-
-
-
-
-
-
-
-
-